miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/β-catenin signaling pathway

被引:10
作者
Wei, Zihao [1 ]
Wang, Yun [2 ]
Jiang, Lu [1 ,4 ]
Ji, Ning [1 ]
Wang, Ying [1 ]
Chen, Fangman [3 ]
Li, Taiwen [1 ]
Li, Jing [1 ]
Xu, Hao [1 ]
Zeng, Xin [1 ,4 ]
Chen, Qianming [1 ,4 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis,State Key Lab Oral Dis, Chinese Acad Med Sci,Res Unit Oral Carcinogenesis, Chengdu, Sichuan, Peoples R China
[2] Sun Yat Sen Univ, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Guangzhou, Guangdong, Peoples R China
[3] Zhejiang Univ, Key Lab Oral Biomed Res Zhejiang Prov, Affiliated Stomatol Hosp, Sch Stomatol,Sch Med, Hangzhou, Zhejiang, Peoples R China
[4] 14,Sec 3,RenMinNan Rd, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNA-223; TCF7L2; Wnt signaling pathway; Neoplasm metastasis; Oral cancer; MESENCHYMAL TRANSITION; EXTRACAPSULAR SPREAD; GASTRIC-CANCER; INVASION; TONGUE; PROLIFERATION; EXPRESSION; MIGRATION; INHIBITOR; MECHANISM;
D O I
10.1016/j.oraloncology.2020.104941
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Metastasis seriously affects the prognosis of patients with oral squamous cell carcinoma (OSCC); however, the precise mechanism remains poorly understood. Materials and methods: microRNA (miRNA) array analysis of four cell lines was used to identify candidate miRNAs. The Cancer Genome Atlas (TCGA) database was used to verify the relationship between candidate miRNAs and OSCC metastasis. Transwell chambers and mouse model experiments were used to analyze OSCC cell migration and invasion abilities in vitro and in vivo. Additionally, bioinformatics and a dual luciferase reporter assay were used to identify selected miRNA target genes. A multicenter clinical cohort of 250 patients with OSCC was set up to evaluate the diagnostic and predicted value of the target genes. Finally, the molecular mechanism of a selected miRNA regulating OSCC metastasis was further explored. Results: miR-223 expression was found to be negatively correlated with OSCC cell invasion and migration abilities. TCGA database data confirmed the relationship between miR-223 expression and OSCC metastasis. Functional experiments indicated that overexpression of miR-223 could decrease the metastasis ability of OSCC cells, while decreasing its expression level led to the enhancement of OSCC metastasis. Bioinformatics and a dual-luciferase reporter assay identified that miR-223 directly targets transcription factor 7-like 2 (TCF7L2). Additionally, TCF7L2 was shown to be negatively correlated with patient metastasis and survival. Conclusions: miR-223 regulates OSCC invasion and metastasis by directly targeting TCF7L2 and potentiating the Wnt/beta-catenin signaling pathway. These findings demonstrate the versatile role of miR-223 in carcinogenesis. miR-223 might serve as an attractive OSCC metastasis intervention target.
引用
收藏
页数:10
相关论文
共 49 条
[1]   Clinical update on head and neck cancer: molecular biology and ongoing challenges [J].
Alsahafi, Elham ;
Begg, Katheryn ;
Amelio, Ivano ;
Raulf, Nina ;
Lucarelli, Philippe ;
Sauter, Thomas ;
Tavassoli, Mahvash .
CELL DEATH & DISEASE, 2019, 10 (8)
[2]   The Role of Carcinogenesis-Related Biomarkers in the Wnt Pathway and Their Effects on Epithelial-Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma [J].
Bai, Yunpeng ;
Sha, Jingjing ;
Kanno, Takahiro .
CANCERS, 2020, 12 (03)
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma [J].
Bozec, Alexandre ;
Zangari, Josephine ;
Butori-Pepino, Mathilde ;
Ilie, Marius ;
Lalvee, Salome ;
Juhel, Thierry ;
Butori, Catherine ;
Brest, Patrick ;
Hofman, Paul ;
Vouret-Craviari, Valerie .
ONCOTARGET, 2017, 8 (34) :57174-57186
[5]   Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol [J].
Cao, Lu ;
Zhang, Xue ;
Cao, Fanfan ;
Wang, Ying ;
Shen, Yufan ;
Yang, Chunxin ;
Uzan, Georges ;
Peng, Bin ;
Zhang, Denghai .
BMC CANCER, 2015, 15
[6]   Targeting cancer stem cells in squamous cell carcinoma [J].
Chen, Demeng ;
Wang, Cun-Yu .
PRECISION CLINICAL MEDICINE, 2019, 2 (03) :152-165
[7]   The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) [J].
Cohen, Ezra E. W. ;
Bell, R. Bryan ;
Bifulco, Carlo B. ;
Burtness, Barbara ;
Gillison, Maura L. ;
Harrington, Kevin J. ;
Quynh-Thu Le ;
Lee, Nancy Y. ;
Leidner, Rom ;
Lewis, Rebecca L. ;
Licitra, Lisa ;
Mehanna, Hisham ;
Mel, Loren K. ;
Raben, Adam ;
Sikora, Andrew G. ;
Uppaluri, Ravindra ;
Whitworth, Fernanda ;
Zandberg, Dan P. ;
Ferris, Robert L. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[8]   Oral Complications of Cancer and Cancer Therapy From Cancer Treatment to Survivorship [J].
Epstein, Joel B. ;
Thariat, Juliette ;
Bensadoun, Rene-Jean ;
Barasch, Andrei ;
Murphy, Barbara A. ;
Kolnick, Leanne ;
Popplewell, Leslie ;
Maghami, Ellie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (06) :401-422
[9]   Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study [J].
Fitzmaurice, Christina .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[10]   The NOTCH4-HEY1 Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma [J].
Fukusumi, Takahito ;
Guo, Theresa W. ;
Sakai, Akihiro ;
Ando, Mizuo ;
Ren, Shuling ;
Haft, Sunny ;
Liu, Chao ;
Amornphimoltham, Panomwat ;
Gutkind, J. Silvio ;
Califano, Joseph A. .
CLINICAL CANCER RESEARCH, 2018, 24 (03) :619-633